Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

NEW ISSUE: The Procter & Gamble Company € bmk 4yr, 8yr, 12yr & 20yr Sr Unsec; MS+65a & MS+95a & MS+115a & MS+145a

IGC European Market: Deal Flow - General

Issuer

Term

Maturity

Size

Ranking

Type

IPT

ISIN

The Procter & Gamble Company

4yr

03-Nov-30

bmk

Sr Unsec

Fixed

MS+65a

XS3553990360

The Procter & Gamble Company

8yr

03-Nov-34

bmk

Sr Unsec

Fixed

MS+95a

XS3553990444

The Procter & Gamble Company

12yr

03-Nov-38

bmk

Sr Unsec

Fixed

MS+115a

XS3553990527

The Procter & Gamble Company

20yr

03-Nov-46

bmk

Sr Unsec

Fixed

MS+145a

XS3553990790


IPTs: 4yr: MS+65a 8yr: MS+95a 12yr: MS+115a 20yr: MS+145a


  • Issuer: The Procter & Gamble Company
  • Ticker: PG
  • LEI: 2572IBTT8CCZW6AU4I41
  • Expected Ratings: Aa3 (Positive) / AA- (Stable) (Moody's/S&P)
  • Format: Senior Unsecured Notes
  • Pricing Date: 27-Oct-26
  • Settlement: 03-Nov-26 (T+5)
  • Size: € Benchmark (each tranche)
  • Maturity:
    • 4yr: 03-Nov-30
    • 8yr: 03-Nov-34
    • 12yr: 03-Nov-38
    • 20yr: 03-Nov-46
  • Coupon: Fixed, Annual, ACT/ACT (ICMA) for all tranches
  • Optional Redemption: MWC for all tranches
  • ISIN / Common Code:
    • 4yr: XS3553990360 / 355399036
    • 8yr: XS3553990444 / 355399044
    • 12yr: XS3553990527 / 355399052
    • 20yr: XS3553990790 / 355399079
  • B&D: DB for all tranches
  • Timing: Books open, Today's business
  • Joint Book-Running Managers: Citi / DB (B&D) / GS / HSBC / MS
  • Target Market: MiFID II and UK MiFIR professionals / ECPs-only / No PRIIPs KID or DISC Disclosure Document
  • Stabilization: FCA / ICMA
  • Selling Restrictions: As per The Procter & Gamble Companys Preliminary Prospectus Supplement
  • Clearing: Euroclear and Clearstream
  • Docs: SEC Registered / New York Stock Exchange Listing / New York Law
  • Denominations: €100,000 x €1,000
  • UoP: General Corporate Purposes
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.